Stöger, Reinhard and Genereux, Diane P. and Hagerman, Randi J. and Hagerman, Paul J. and Tassone, Flora and Laird, Charles D. (2011) Testing the FMR1 promoter for mosaicism in DNA methylation

Variability among individuals in the severity of fragile X syndrome (FXS) is influenced by epigenetic methylation mosaicism, which may also be common in other complex disorders. The epigenetic signal of dense promoter DNA methylation is usually associated with gene silencing, as was initially reported for FMR1 alleles in individuals with FXS. A paradox arose when significant levels of FMR1 mRNA were reported for some males with FXS who had been reported to have predominately methylated alleles. We have used hairpin-bisufite PCR, validated with molecular batch-stamps and barcodes, to collect and assess double-stranded DNA methylation patterns from these previously studied males. These patterns enable us to distinguish among three possible forms of methylation mosaicism, any one of which could explain FMR1 expression in these males. Our data indicate that cryptic inter-cell mosaicism in DNA methylation can account for the presence of FMR1 mRNA in some individuals with FXS. Citation: Stöger R, Genereux DP, Hagerman RJ, Hagerman PJ, Tassone F, et al. (2011) Testing the FMR1 Promoter for Mosaicism in DNA Methylation among CpG Sites, Strands, and Cells in FMR1-Expressing Males with Fragile X Syndrome. PLoS ONE 6(8): e23648. doi:10.1371/journal.pone.0023648 Editor: Esteban Ballestar, Bellvitge Biomedical Research Institute (IDIBELL), Spain Received January 14, 2011; Accepted July 22, 2011; Published August 31, 2011 Copyright: 2011 Stöger et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: This research was supported by National Institutes of Health (NIH) grants HD002274, GM077464 and NIH Genome Training Grant T32 HG 00035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist. * E-mail: [email protected] (RS); [email protected] (CL)